Please wait while we open this resource.
K
Clinical reviews
THE ROLE OF β-BLOCKERS IN THE EVOLVING TREATMENT LANDSCAPE OF RESISTANT HYPERTENSION
Stefano Masi, Atul Pathak, Rosa Maria Bruno, Sofie Brouwers, Krzysztof Narkiewicz, Stefano Taddei, Konstantinos Tsioufis, Reinhold Kreutz
PDF202621 pages1.6 MB
Resistant hypertension (RHTN) affects approximately 15% of patients with hypertension and is associated with increased cardiovascular risk. The review discusses the pathophysiological mechanisms underlying RHTN, including the activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system. It also highlights recent clinical trials and guidelines that inform the management of RHTN, emphasizing the therapeutic role of β-blockers and other emerging treatments.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology